In This Section

Board of Directors

Nina Bhardwaj, MD, PhD

Nina Bhardwaj, MD, PhD

(2021-2024)

Ward Coleman Chair in Cancer Research
Director of Immunotherapy
Medical Director, Vaccine and Cell Therapy Laboratory
Codirector, Cancer Immunology Program
The Tisch Cancer Institute
Icahn School of Medicine at Mt. Sinai
New York, New York

John D. Carpten, PhD, FAACR

John D. Carpten, PhD, FAACR

(2021-2024)

Professor and Chair, Department of Translational Genomics
Royce and Mary Trotter Chair in Cancer Research
Professor, Department of Urology
Co-director, Institute for Translational Genomics
Director, USC Molecular Genomics Core
Co-leader, NCCC Translational and Clinical Sciences Program
PI-CaRE2 Health Equity Center at USC
Keck School of Medicine
University of Southern California

Marcia R. Cruz-Correa, MD, PhD, AGAF, FASGE

Marcia R. Cruz-Correa, MD, PhD, AGAF, FASGE

(2019-2022)

Executive Director and Professor of Medicine, Biochemistry, and Oncology
University of Puerto Rico Comprehensive Cancer Center
Gastrointestinal Oncology Program Director
Isaac Gonzalez Martinez Oncologic Hospital
San Juan, Puerto Rico

Luis A. Diaz Jr., MD

Luis A. Diaz Jr., MD

(2021-2024)

Grayer Family Chair
Head, Division of Solid Tumor Oncology
Memorial Sloan Kettering Cancer Center
New York, New York

Keith T. Flaherty, MD

Keith T. Flaherty, MD

(2019-2022)

Director of Clinical Research, Massachusetts General Hospital Cancer Center
Professor of Medicine, Harvard Medical School
Boston, Massachusetts

Silvia Chiara Formenti, MD

Silvia Chiara Formenti, MD

(2020-2023)

Sandra and Edward Meyer Professor of Cancer Research
Professor and Chairman, Department of Radiation Oncology
Weill Cornell Medicine
Associate Director, Sandra and Edward Meyer Cancer Center
Radiation Oncologist-in-Chief
New York Presbyterian Hospital
New York, New York

Elaine Fuchs, PhD, FAACR

Elaine Fuchs, PhD, FAACR

(2020-2023)

Rebecca C. Lancefield Professor and Investigator
Howard Hughes Medical Institute
The Rockefeller University
New York, New York

Susan M. Galbraith, MBBChir, PhD, MRCP, FRCR, FMedSci

Susan M. Galbraith, MBBChir, PhD, MRCP, FRCR, FMedSci

(2021-2024)

Senior Vice President
Head of Research and Early Development
Oncology R&D
AstraZeneca
Cambridge, England

Roy S. Herbst, MD, PhD

Roy S. Herbst, MD, PhD

(2020-2023)

Ensign Professor of Medicine
Professor of Pharmacology
Chief of Medical Oncology
Associate Director for Translational Research
Yale Comprehensive Cancer Center
Yale School of Medicine
New Haven, Connecticut

Thomas J. Lynch Jr., MD

Thomas J. Lynch Jr., MD

(2021-2024)

President and Director
Raisbeck Endowed Chair
Fred Hutchinson Cancer Research Center
Seattle, Washington

Ira Mellman, PhD

Ira Mellman, PhD

(2020-2023)

Vice President, Cancer Immunology
Genentech Inc.
South San Francisco, California

Lisa A. Newman, MD, MPH, FACS, FASCO, FSSO

Lisa A. Newman, MD, MPH, FACS, FASCO, FSSO

(2021-2024)

Chief, Section of Breast Surgery
New York-Presbyterian/Weill Cornell Medical Center
Leader, Multidisciplinary Breast Oncology Programs
New York-Presbyterian David H. Koch Center
Weill Cornell Medicine

Martine F. Roussel, PhD, FAACR

Martine F. Roussel, PhD, FAACR

(2019-2022)

Endowed Chair in Molecular Oncogenesis
Co-leader, Cancer Biology Cancer Center Program
Danny Thomas Research Center, St. Jude Children’s Research Hospital
Memphis, Tennessee

Charles Swanton, MBPhD, FRCP, FMedSci, FRS, FAACR

Charles Swanton, MBPhD, FRCP, FMedSci, FRS, FAACR

(2019-2022)

Royal Society Napier Professor
The Francis Crick Institute and UCL Cancer Institute
Cancer Evolution and Genome Instability Lab
The Francis Crick Institute
London, England

Suzanne L. Topalian, MD

Suzanne L. Topalian, MD

(2020-2023)

Professor of Surgery and Oncology and Associate Director
Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy
Director, Melanoma Program, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland

View the list of past board members.